Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Kavanagh, Dara O ^a   Chambers, Gillian ^a   O'Grady, Liam ^a   Barry, Kevin M ^a   Waldron, Ronan P ^a   Bennani, Fadel ^a   Eustace, Paul W ^a   Tobbia, Iqdam ^a  

^a MAYO GENERAL HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; PARAFFIN;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; RECURRENCE RISK; SEX DIFFERENCE; COHORT ANALYSIS; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2;

EID: 61749084470     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-1     Document Type: Article

References (25)

1. Jemal A Murray T Samuels A Ghafoor A Ward E Thun MJ Cancer statistics Ca Cancer J Clin 2003, 53:5-26. 12568441
2. Steele RJC Colorectal Surgery Elsevier 2005, 3:41-67.
3. Hurwitz H Fehrenbacher L Novotny W Cartwright T Hainsworth J Heim W Berlin J Baron A Griffing S Holmgren E Ferrara N Fyfe G Rogers B Ross R Kabbinavar F Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer New Engl J Med 2004 ,3:350(23):2335-42. 10.1056/NEJMoa032691
4. Slamon DJ Clark GM Wong SG Levin WJ Ullrich A McGuire WL Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 1987, 9;235(4785):177-82. 10.1126/ science.3798106
5. Leonard DS Hill AD Kelly L Djikstra B McDermott E O' Higgins NJ Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer Br J Surg 2002, 89(3):262-71. 10.1046/ j.0007-1323.2001.02022.x 11872048
6. Olayioye MA Neve RM Lane HA Hynes NE The erbβ signalling network: heterodimerisation in development and cancer EMBO J 2000, 19:3159-67. 313958 10880430 10.1093/emboj/19.13.3159
7. Slamon DJ Leyland-Jones B Shak S Fuchs H Paton V Bajamonde A Fleming T Eiermann W Wolter J Pegram M Baselga J Norton L Use of chemotherapy plus a monoclonal antibody against HER-2 for metastatic breast cancer that over expresses HER-2 N Engl J Med 2001, 344:783-792. 10.1056/ NEJM200103153441101 11248153
8. Vogel CL Cobleigh MA Tripathy D Gutheil JC Harris LN Fehrenbacher L Slamon DJ Murphy M Novotny WF Burchmore M Shak S Stewart SJ Press M Efficacy and safety of trastuzumab as a single agent in first line treatment of HER-2 over expressing metastatic breast cancer J Clin Oncol 2002, 20(3):719-726. 10.1200/JCO.20.3.719 11821453
9. Mann M Sheng H Shao J Williams CS Pisacane PI Sliwkowski MX DuBois RN Targeting cyclooxygenase 2 and HER-2/neu pathway inhibits colorectal carcinoma growth Gastroenterology 2001, 120:1713-9. 10.1053/ gast.2001.24844 11375952
10. Ross JS McKenna BJ The HER-2/neu oncogene in tumours of the gastrointestinal tract Cancer Invest 2001, 19:554-68. 10.1081/ CNV-100103852 11458821
11. Osako T Miyhara M Inomata M Kitano S Kobayashi M Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival Oncology 1998, 55:549-55. 10.1159/000011911
12. Park DI Kang MS Oh SJ Kim HJ Cho YK Sohn CI Jeon WK Kim BI Han WK Kim H Ryu SH Sepulveda AR HER-2/neu overexpression is an independent prognostic factor in colorectal cancer Int J Colorectal Dis 2007, 22:491-7. 10.1007/s00384-006-0192-8 16947041
13. Caruso ML Valentini AM Immunohistochemical p53 overexpression correlated to c-erbB2 and cathepsin D proteins in colorectal cancer Anticancer Res 1996, 16:3813-8. 9042263
14. Kapitanovic S Radosevic S Kapitanovic M Andelinovic S Ferencic Z Tavalossi M Primorać D Sonicki Z Spaventi S Pavelic K Spaventi R The expression of p185 (HER-2/neu) correlates with the stage of disease and survival in colorectal cancer Gastroenterology 1997, 112:1103-13. 10.1016/S0016-5085(97)70120-3 9097992
15. McKay JA Loane JF Ross VG Ameyaw MM Murray GI Cassidy J McLeod HL C-erbB-2 is not a major factor in the development of colorectal cancer Br J Canc 2002, 86:568-573. 10.1038/sj.bjc.6600127
16. D'Emilia J Bulovas K D'Ercole K Wolf B Steele G Jr Summerhayes IC Expression of c-erbB2 gene product (p185) at different stages of neoplastic progression in the colon Oncogene 1989, 4:1233-39. 2571966
17. Essapen S Thomas H Green M De Vries C Cook MG Marks C Topham C Modjtahedi H The expression and prognostic significance of HER-2 in CRC Int J Oncol 2004, 24(20):241-8. 14719098
18. Half E Broaddus R Danenburg KD Danenburg PV Ayers GD Sinicrope FA HER-2 receptor expression, localisation and activation in colorectal cancer cell lines and human tumours Int J Cancer 2004, 108:540-548. 10.1002/ ijc.11599 14696118
19. Pauletti G Godolphin W Press MF Slamon DJ Detection and quantification of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridisation Oncogene 1996, 13:63-72. 8700555
20. Winston JS Ramanaryanan J Levine E HER-2/neu evaluation in breast cancer are we there yet? Am J Clin Pathol 2004, 121(Suppl):S33-49. 15298149
21. Lazaris AC Theodoropoulos GE Anastassopulos T Nakopoulou L Panoussopoulos D Papadimitriou K Prognostic significance of p53 and c-erbB2 immunohistochemical evaluation in colorectal adenocarcinoma Histol Histopathol 1995, 10(3):661-8. 7579815
22. Schuell B Gruenberger T Scheithauer W Zielinski Ch Wrba F Her-2/neu protein expression in colorectal cancer BMC Cancer 2006, 6:123. 1475876 16681853 10.1186/1471-2407-6-123
23. Nathanson DR Culliford AT 4th Shia J Chen B D'Alessio M Zeng ZS Nash GM Gerald W Barany F Paty PB Her-2/neu expression and gene amplification in colon cancer Int J Cancer 2003, 105:796-802. 10.1002/ijc.11137 12767065
24. Ramanathan RK Hwang JJ Zamboni WC Sinicrope FA Safran H Wong MK Earle M Brufsky A Evans T Troetschel M Walko C Day R Chen HX Finkelstein S Low expression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan therapy. A phase II trial Cancer Invest 2004, 22(6):858-65. 10.1081/CNV-200039645 15641483
25. Jiang Y Casey G Lavery IC Zhang Y Talantov D Martin-McGreevy M Skacel M Manilich E Mazumder A Atkins D Delaney CP Wang Y Development of a Clinically Feasible Molecular Assay to Predict Recurrence of Stage II Colon Cancer J Mol Diagn 2008, 10(4):346-54. 10.2353/jmoldx.2008.080011 18556775